Research Topics
| Barbara TempalskiSummaryAffiliation: National Development and Research Institutes Country: USA Publications
| Collaborators
|
Detail Information
Publications
Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drugBarbara Tempalski
National Development and Research Institutes, Inc, New York, NY, USA
Int J Drug Policy 19:S47-58. 2008..Notably, we know little about variations in syringe coverage within the U.S. and elsewhere, or about the social and political factors that might determine this coverage...- Persistence of low drug treatment coverage for injection drug users in large US metropolitan areasBarbara Tempalski
National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Fl, New York, NY 10010, USA
Subst Abuse Treat Prev Policy 5:23. 2010..Yet, little is known about changes in drug treatment availability for IDUs in the U.S. This paper investigates change in drug treatment coverage for IDUs in 90 metropolitan statistical areas (MSAs) during 1993-2002... - HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002Barbara Tempalski
National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
J Urban Health 86:132-54. 2009..These results warrant further research into the population dynamics of disease progression, access to health services, and the effects of HIV prevention interventions for IDUs... - Placing the dynamics of syringe exchange programs in the United StatesBarbara Tempalski
National Development and Research Institutes, Inc, 71 West 23rd St, 8F, NY 10010, USA
Health Place 13:417-31. 2007..Action on this issue occurs locally, and the characteristics of place-based factors affect whether particular areas adopt SEPs... 
Drugscapes and the role of place and space in injection drug use-related HIV risk environmentsBarbara Tempalski
National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
Int J Drug Policy 20:4-13. 2009..As such, we consider in this commentary the importance of geographic place and the socio-spatial and political processes related to place that may help determine where IDU-related HIV risk environments occur...- Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areasBarbara Tempalski
Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
Am J Public Health 97:437-47. 2007..Need was not a predictor... 
Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of AmericaSamuel R Friedman
National Development and Research Institutes, New York, NY 10010, USA
Int J Drug Policy 18:475-85. 2007..Here, we determine which metropolitan area characteristics are associated with drug treatment coverage...- HIV among injection drug users in large US metropolitan areas, 1998Samuel R Friedman
Institute for AIDS Research, National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
J Urban Health 82:434-45. 2005.... - Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areasEnrique R Pouget
National Development and Research Institutes, Inc, New York, NY, USA
J Urban Health 89:527-64. 2012..Future research should attempt to determine to what extent these trends are applicable to Hispanic national origin subgroups... - Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areasSudip Chatterjee
National Development and Research Institutes, Inc, New York, NY 10010, USA
AIDS Behav 15:1570-8. 2011..64) to 2002 (mean = 115.59). Additional analyses of the proportion of young IDUs using health services suggest this increase may have continued after 2002. Harm reduction and prevention research and programs for young IDUs are needed... - Residential segregation and injection drug use prevalence among Black adults in US metropolitan areasHannah L F Cooper
Medical and Health Research Association of New York City, Inc, New York, NY, USA
Am J Public Health 97:344-52. 2007..We analyzed the relations of two 1990 dimensions of racial residential segregation (isolation and concentration) with 1998 injection drug use prevalence among Black adult residents of 93 large US metropolitan statistical areas (MSAs)... - Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002Joanne E Brady
Institute for AIDS Research, National Development and Research Institutes, Inc NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
J Urban Health 85:323-51. 2008.... - Drug arrests and injection drug deterrenceSamuel R Friedman
National Development and Research Institutes, Inc, New York, NY 10010, USA
Am J Public Health 101:344-9. 2011..We tested the hypothesis that higher rates of previous hard drug-related arrests predict lower rates of injection drug use... - Distance traveled and cross-state commuting to opioid treatment programs in the United StatesAndrew Rosenblum
National Development and Research Institutes, Inc NDRI, 71 W 23 Street, 8th Floor, New York, NY 10010, USA
J Environ Public Health 2011:948789. 2011..To reduce obstacles to OTP access, policy makers and treatment providers should be alert to patients' commuting patterns and to factors associated with them... - Diffusion of the D.A.R.E and syringe exchange programsDon C Des Jarlais
Beth Israel Medical Center, New York, NY 10038, USA
Am J Public Health 96:1354-8. 2006..The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations... - Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areasSamuel R Friedman
National Development and Research Institutes, New York, NY 10010, USA
AIDS 20:93-9. 2006..To understand associations of punitive policies to the population prevalence of injection drug users and to HIV seroprevalence among injectors... - Racial/ethnic disparities in injection drug use in large US metropolitan areasHannah Cooper
Medical and Health Research Association of New York City, Inc, NY, USA
Ann Epidemiol 15:326-34. 2005.... - Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug usersSamuel R Friedman
Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
J Urban Health 81:377-400. 2004..Although service provision levels varied considerably, few if any metropolitan areas seemed to be providing adequate levels of services... - A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesBrandon D L Marshall
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, United States of America
PLoS ONE 7:e44833. 2012..We describe the development of a conceptual framework and calibration of an agent-based model (ABM) to examine how combinations of interventions may reduce and potentially eliminate HIV transmission among drug-using populations... - Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSSamuel R Friedman
Institute of Infectious Disease Research, National Development and Research Institutes, Inc, New York, New York, United States of America
PLoS ONE 8:e57201. 2013..We assess metropolitan area characteristics associated with decline in mortality rates among IDUs living with AIDS (per 10,000 adult MSA residents) after highly active antiretroviral therapy (HAART) was developed... - Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditisHannah L F Cooper
National Development and Research Institutes, New York, NY, USA
Clin Infect Dis 45:1200-3. 2007..e., injection drug users) remained stable. Increasing methamphetamine use and/or drug injection frequency may have increased the incidence of infective endocarditis among active injection drug users...